Robert Hromas
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Immunology top 0.5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
-
- DNA Repair Mechanisms 66
- Epigenetics and DNA Methylation 26
- CRISPR and Genetic Engineering 19
- Genomics and Chromatin Dynamics 15
- Oncology 64
- PARP inhibition in cancer therapy 17
- Chemokine receptors and signaling 16
- Co-authors
- Daniel G. Tenen (4 shared papers)Dong‐Er Zhang (4 shared papers)Jonathan D. Licht (2 shared papers)Hal E. Broxmeyer (18 shared papers)Jac A. Nickoloff (35 shared papers)Elizabeth A. Williamson (46 shared papers)M Klemsz (9 shared papers)Suk‐Hee Lee (27 shared papers)
- Journals
- Blood (28 papers)Journal of Biological Chemistry (12 papers)Proceedings of the National Academy of Sciences (7 papers)Cancer Research (7 papers)Journal of Clinical Oncology (6 papers)
- Partner nations
- United StatesFranceChina
In The Last Decade
Robert Hromas
206 papers receiving 10.3k citations
Robert Hromas's Hit Papers
Peers
Comparison fields: 5 of 135
- Hematology 1.6k
- Immunology 2.5k
- Oncology 2.5k
- Molecular Biology 5.8k
- Cancer Research 884
Countries citing papers authored by Robert Hromas
This map shows the geographic impact of Robert Hromas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Hromas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Hromas more than expected).
Fields of papers citing papers by Robert Hromas
This network shows the impact of papers produced by Robert Hromas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Hromas. The network helps show where Robert Hromas may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Hromas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 209 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Transcription Factors, Normal Myeloid Development, and Leukemia Hit paper breakdown → | 1997 | 632 |
| 2 | Transcription Factors, Normal Myeloid Development, and Leukemia Hit paper breakdown → | 1997 | 586 |
| 3 | 1993 | 399 | |
| 4 | 2001 | 280 | |
| 5 | 2002 | 256 | |
| 6 | 2010 | 226 | |
| 7 | 2000 | 212 | |
| 8 | 1997 | 210 | |
| 9 | 1993 | 183 | |
| 10 | 1994 | 173 | |
| 11 | 2020 | 171 | |
| 12 | 1991 | 169 | |
| 13 | 1999 | 168 | |
| 14 | 1997 | 154 | |
| 15 | 1996 | 149 | |
| 16 | 2011 | 140 | |
| 17 | 2002 | 127 | |
| 18 | 1997 | 125 | |
| 19 | 1994 | 124 | |
| 20 | 2005 | 121 |
About Robert Hromas
Robert Hromas is a scholar working on Molecular Biology, Oncology, Immunology, Hematology and Genetics, having authored 209 papers that have together received 10.5k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (66 papers), Epigenetics and DNA Methylation (26 papers), Acute Myeloid Leukemia Research (23 papers), CRISPR and Genetic Engineering (19 papers), PARP inhibition in cancer therapy (17 papers), Chemokine receptors and signaling (16 papers), Genomics and Chromatin Dynamics (15 papers) and Immunotherapy and Immune Responses (14 papers). The work is most often cited by research in Hematology (1.6k citations), Immunology (2.5k citations), Oncology (2.5k citations), Molecular Biology (5.8k citations) and Cancer Research (884 citations). Robert Hromas has collaborated with scholars based in United States, France and China. Frequent co-authors include Daniel G. Tenen, Dong‐Er Zhang, Jonathan D. Licht, Hal E. Broxmeyer, Jac A. Nickoloff, Elizabeth A. Williamson, M Klemsz, Suk‐Hee Lee, Michael J. Robertson and Kent W. Christopherson. Their work appears in journals such as Blood, Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, Cancer Research and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.